PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs
← catalyst calendarSponsored by PROCEPT BioRobotics (industry) · PRCT — their whole pipeline →.
Phase
Not applicable
Status
Active, not recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
125actual
Sites
6
Countries
Hong Kong, Lebanon, New Zealand +1
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2022-11-22 | actual | When the study began enrolling |
| Primary completion | Jul 2026 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Mar 2027 | estimated | The whole study's end, after follow-up |
| First posted | 2023-09-25 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-01-28 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Benign Prostatic Hyperplasia
- Localized Prostate Cancer
Intervention
- Device: Robotic Waterjet Treatment — also filed as Aquablation therapy
Primary outcome
what the primary-completion date above is the date OFIncidence of Clavien-Dindo Adverse Events (Percentage of Participants) Through 3 Months Post Treatment
measured 3 months post-treatment
Permalink · PRCT's whole pipeline · Catalyst calendar · Every registered study · What changed